[
  {
    "ts": "2025-08-28T12:48:00+00:00",
    "headline": "CRSP vs. BEAM: Which Gene Editing Stock Holds More Potential Right Now?",
    "summary": "CRISPR Therapeutics gains momentum with Casgevy sales and a broader pipeline, while Beam Therapeutics advances base-editing therapies still in early stages.",
    "url": "https://finance.yahoo.com/news/crsp-vs-beam-gene-editing-124800525.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "86e7dacd-3f64-3092-a847-d0da47ab4d7f",
      "content": {
        "id": "86e7dacd-3f64-3092-a847-d0da47ab4d7f",
        "contentType": "STORY",
        "title": "CRSP vs. BEAM: Which Gene Editing Stock Holds More Potential Right Now?",
        "description": "",
        "summary": "CRISPR Therapeutics gains momentum with Casgevy sales and a broader pipeline, while Beam Therapeutics advances base-editing therapies still in early stages.",
        "pubDate": "2025-08-28T12:48:00Z",
        "displayTime": "2025-08-28T12:48:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/56d1b0639f9b169b5b1e773c99d1da8d",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/1PfCTlsobe085hq9kQ39eQ--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/56d1b0639f9b169b5b1e773c99d1da8d.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/CtPCfYhWGdEMh.kVEHgTDw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/56d1b0639f9b169b5b1e773c99d1da8d.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/crsp-vs-beam-gene-editing-124800525.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/crsp-vs-beam-gene-editing-124800525.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": null,
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]